ClinicalTrials.gg
CompletedNCT07649876Updated Oct 23, 2026

Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients

An interventional study of Virtual reality (VR) therapy in Delirium in the Intensive Care Unit, Sleep Quality in Adult ICU Patients and Agitation Associated With Critical Illness, sponsored by Milton S. Hershey Medical Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Prevention

How we know

Updated Oct 23, 2026Now CompletedEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Pain by Milton S. Hershey Medical Center — none open to participants now, 1 under way, none of them phase 3. Pain · Milton S. Hershey Medical Center.

Started
2026
the only one that year
No phase
6 of 12
none open now
Registered
12th of 12
by date

Among the 12 studies in Pain by Milton S. Hershey Medical Center, this one is the only one that started in 2026, is one of 6 with no phase, and was the 12th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

None of the 12 studies in Pain by Milton S. Hershey Medical Center is open now. The open studies under Pain, anywhere →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 12 studies in Pain by Milton S. Hershey Medical Center as a file.
02

Study summary

This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research

03

Conditions studied

  • Delirium in the Intensive Care Unit
  • Sleep Quality in Adult ICU Patients
  • Agitation Associated With Critical Illness
  • Anxiety Acute

Keywords

  • Virtual reality
  • Intensive care unit
  • Pain
  • Agitation
  • Anxiety
  • Sleep Quality
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged ≥ 18 years old admitted to the Surgical Intensive Care Unit (SICU) at Penn State Health Milton S. Hershey Medical Center.
  2. No significant uncorrectable visual or auditory impairments
  3. Estimated ICU length of stay > 48h
  4. At the time of each VR session, able to keep eyes open for at least 30 seconds, follow simple commands and able to indicate discomfort or request to stop.
  5. English speaking

Exclusion criteria

Exclusion Criteria:

  1. Significant hemodynamic instability
  2. Known psychotic disorders associated with delusions (e.g. schizophrenia)
  3. Severe dementia (e.g. inability to communicate or follow simple commands)
  4. History of disequilibrium syndrome or vertigo
  5. Acute hyperactive delirium, requiring physical restraints
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    VR Intervention

    Critically ill patients

    Behavioral: Virtual reality (VR) therapy

Interventions

  • BehavioralVirtual reality (VR) therapy

    VR sessions will use a commercially available headset with non-interactive, immersive content displaying calming nature-based content (e.g., ocean/beach scenes, forests, mountains) delivered through a commercially available VR application

06

What researchers measure

Primary outcomes

  1. Feasibility of Intervention Measure (FIM)

    Time frame: From time of enrollment to end of intervention at 3 days

  2. Acceptability of Intervention Measure (AIM)

    Time frame: From time of enrollment to end of intervention at 3 days

  3. Intervention Appropriateness Measure (IAM)

    Time frame: From time of enrollment to end of intervention at 3 days

07

Study locations

1 site
  • Penn State Milton S. Hershey Medical Center
    Hershey, Pennsylvania 17033, United States
08

References and documents

Publications

  • Haley AC, Wacker DA. Cinematic virtual reality for anxiety management in mechanically ventilated patients: a feasibility and pilot study. Acute Crit Care. 2022 May;37(2):230-236. doi: 10.4266/acc.2021.00843. Epub 2022 Feb 4. PubMed 35172527 ↗
  • Locke BW, Tsai TY, Reategui-Rivera CM, Gabriel AS, Smiley A, Finkelstein J. Immersive Virtual Reality Use in Medical Intensive Care: Mixed Methods Feasibility Study. JMIR Serious Games. 2024 Aug 9;12:e62842. doi: 10.2196/62842. PubMed 39046869 ↗
  • Naef AC, Jeitziner MM, Gerber SM, Jenni-Moser B, Muri RM, Jakob SM, Nef T, Hanggi M. Virtual reality stimulation to reduce the incidence of delirium in critically ill patients: study protocol for a randomized clinical trial. Trials. 2021 Mar 1;22(1):174. doi: 10.1186/s13063-021-05090-2. PubMed 33648572 ↗
  • Ong TL, Ruppert MM, Akbar M, Rashidi P, Ozrazgat-Baslanti T, Bihorac A, Suvajdzic M. Improving the Intensive Care Patient Experience With Virtual Reality-A Feasibility Study. Crit Care Explor. 2020 Jun 8;2(6):e0122. doi: 10.1097/CCE.0000000000000122. eCollection 2020 Jun. PubMed 32695991 ↗
  • Jawed YT, Golovyan D, Lopez D, Khan SH, Wang S, Freund C, Imran S, Hameed UB, Smith JP, Kok L, Khan BA. Feasibility of a virtual reality intervention in the intensive care unit. Heart Lung. 2021 Nov-Dec;50(6):748-753. doi: 10.1016/j.hrtlng.2021.05.007. Epub 2021 Jul 1. PubMed 34217986 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Sep 2026, 2 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 2 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jun 16, 2026
StartActual
Jun 2, 2026
Primary completionActual
Sep 1, 2026
CompletionActual
Sep 15, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 23, 2026
Enrollment
30 (estimated)→20 (actual)
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Recruiting→Completed
    Enrollment 30 (estimated)→20 (actual)
    + 4 other changes: verification date, date precision, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07649876
Responsible party
Pauline Go (Principal Investigator, Milton S. Hershey Medical Center) — Principal investigator
First posted
Jun 16, 2026
Start date
Jun 2, 2026
Primary completion
Sep 1, 2026
Completion
Sep 15, 2026
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion